Isobionics and BASF Transaction

William Blair acted as the exclusive financial advisor to Isobionics, in connection with its sale to BASF SE (XTRA:BAS).

William Blair Honors CFA Charterholders at Annual Luncheon

William Blair recognized six employees who recently earned their chartered financial analyst designation at its annual CFA Luncheon.

Will Trump Weaponize the Dollar

In this week’s Economic Weekly, we take a look at the dollar and why it could turn out to be the President’s next avenue of attack in attempting to make the U.S. more competitive again, and how he might try to go about achieving this.

IDology and GB Group

William Blair acted as exclusive financial advisor to IDology, a leading provider of digital identity verification and fraud prevention services, in connection with its pending acquisition by GB Group.

Five Themes for Public Company Board Agendas in 2022

There is a lot to consider in the current M&A and corporate finance environment. Despite the volatility and uncertainty of the market, broader strategic topics remain top-of-mind for business leaders and boardrooms.

Restaurant Technology Jan 2020

The COVID-19 pandemic has pushed the restaurant industry to utilize technology platforms more than ever before. We explore some of the key factors driving restaurant technology M&A today.

Key Factors Driving Activity in Commercial Aerospace

Dealmaking is picking up in commercial aerospace. Private equity sponsors and strategic buyers are seeking businesses that are well positioned to benefit from the sector’s post-pandemic rebound. We discuss key valuation drivers in the current M&A environment.

Philanthropy in the Age of Constant Disruption

Report on trends reshaping philanthropic giving now available.

Youth Helping Communities

Vestar Capital Partners and PetHonesty Transaction

William Blair acted as exclusive financial advisor to Vestar Capital Partners in connection with the majority investment in PetHonesty, a leader in premium pet supplements.